Atossa Genetics Company Insiders

ATOS Stock  USD 0.84  0.03  3.45%   
Atossa Genetics' insiders are aggressively buying. The analysis of insiders' sentiment of trading Atossa Genetics stock suggests that vertually all insiders are extremely bullish at this time. Atossa Genetics employs about 15 people. The company is managed by 9 executives with a total tenure of roughly 35 years, averaging almost 3.0 years of service per executive, having 1.67 employees per reported executive.

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2025-05-21Steven C QuayAcquired 11239 @ 0.88View
2025-03-26H. Lawrence RemmelAcquired 10000 @ 0.7View
Monitoring Atossa Genetics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Atossa Genetics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2167) % which means that it has lost $0.2167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3487) %, meaning that it created substantial loss on money invested by shareholders. Atossa Genetics' management efficiency ratios could be used to measure how well Atossa Genetics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.35 in 2025. Return On Capital Employed is likely to drop to -0.41 in 2025. At this time, Atossa Genetics' Non Currrent Assets Other are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 78.2 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 1.9 M in 2025.
Common Stock Shares Outstanding is likely to gain to about 132.2 M in 2025, whereas Net Loss is likely to drop (25.5 M) in 2025.

Atossa Genetics Workforce Comparison

Atossa Genetics is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 389. Atossa Genetics holds roughly 15.0 in number of employees claiming about 4% of equities under Health Care industry.

Atossa Genetics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Atossa Genetics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Atossa Genetics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Atossa Genetics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Atossa Genetics Notable Stakeholders

An Atossa Genetics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Atossa Genetics often face trade-offs trying to please all of them. Atossa Genetics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Atossa Genetics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
RAC MSPHVP of Regulatory Affairs and QualityProfile
Heather CPASenior OfficerProfile
Michael ParksVice RelationsProfile
Heather ReesVP AccountingProfile
FCAP MDCEO ChairmanProfile
Delly PHRSenior OperationsProfile
Eric ZantenVice RelationsProfile
Richard MDInterim OfficerProfile
CPA EsqGen CFOProfile

About Atossa Genetics Management Performance

The success or failure of an entity such as Atossa Genetics often depends on how effective the management is. Atossa Genetics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Atossa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Atossa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.33)(0.35)
Return On Capital Employed(0.39)(0.41)
Return On Assets(0.33)(0.35)
Return On Equity(0.36)(0.37)
Please note, the imprecision that can be found in Atossa Genetics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Atossa Genetics. Check Atossa Genetics' Beneish M Score to see the likelihood of Atossa Genetics' management manipulating its earnings.

Atossa Genetics Workforce Analysis

Traditionally, organizations such as Atossa Genetics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Atossa Genetics within its industry.

Atossa Genetics Manpower Efficiency

Return on Atossa Genetics Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.7M
Net Loss Per Executive2.8M
Working Capital Per Employee4.6M
Working Capital Per Executive7.7M

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.